A phase I trial to investigate the effect of recombinant malaria vaccine.
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2015
At a glance
- Drugs Px 533 (Primary)
- Indications Malaria
- Focus Adverse reactions
- 30 Mar 2015 New trial record
- 16 Mar 2015 According to Pfenex media release, company is planning to initiate this trial in 2015.